It says patients who lose modest amounts early, in the range of one to three pounds, often achieve the best long-term outcomes because they tolerate the medication, avoid excessive nausea, and stay adherent
By enhancing the body's natural insulin release and reducing excessive glucagon secretion, Rybelsus effectively lowers fasting and postprandial blood glucose levels
Getting started was simple, and the results are real
These findings support the idea that some patients may have partial biologic resistance to incretin-based therapies, said Robert Glatter, MD, attending physician in the Department of Emergency Medicine at Lenox Hill Hospital in New York City, and Assistant Professor of Emergency Medicine at Zucker School of Medicine at Hofstra/ Northwell
Individuals with certain genetic profiles may achieve optimal results at lower doses, while others may require higher amounts to reach the same outcome